The Joint Center at AAMC is piloting a program for joint replacement patients where an in-home evaluation is provided by an outpatient physical therapist to review the patient’s function prior to surgery. The therapist assesses the patient’s home and provides recommendations for set up changes to make before surgery to improve patient safety. Once they return home, the patient will receive one or two additional in-home therapy sessions before their transition to outpatient rehab. This program provides opportunity for a quicker discharge and a shorter length of stay, while maintaining quality care. The pilot program is rolling out doctor by doctor until all joint patients are included. The long-term goal is to expand this program beyond The Joint Center patients to other surgical programs at the hospital. For more information on in-home PT, contact Amanda Adkins at 443-481-1418 or email@example.com.
Medical Staff Updates
- Mark Flasar, MD: When your gut talks, pay attention
- Ray Hoffman, MD: AAMC pursuing mental health unit
- Ray Hoffman, MD: AAMC seeks to open mental health unit
- Adrian Park, MD: Surgeons using stretches to improve health, performance
- Adrian Park, MD: Surgeons…get moving!
- Ben Petre, MD: Tips for avoiding lacrosse injuries
- Elizabeth Winter, MD: Ending the epidemic: Federal lawmakers, AAMC host roundtable on growing opioid abuse
- Yong Zheng, MD: Questions women should be asking their doctor
Maulik S. Joshi, DrPH, will join Anne Arundel Medical Center on May 16 as Executive Vice President of Integrated Care Delivery and Chief Operating Officer (EVP and COO). This “next-generation COO” is a new, transformational position for AAMC, and one that will help the organization to continue to move toward Vision 2020: Living Healthier Together. Maulik will help shape the future of healthcare delivery both at AAMC and in Maryland.
Maulik has more than 24 years of varied healthcare experience and currently serves as the Associate Executive Vice President at the American Hospital Association (AHA) and President of the Health Research & Educational Trust. He brings a unique skill set to this new role that will advance AAMC’s work in service excellence, quality, wellbeing, health equity and population health. Through Maulik’s leadership, AAMC will continue to broaden capabilities in population health while maintaining our focus on providing the highest quality, safety and service, delivering on patient- and family-centered care, and driving best practices. In addition to his work with the AHA, Maulik is a published author on the topic of healthcare transformation. His leadership and experience will be invaluable as AAMC continues to grow in the areas of population health and delivering care outside the walls of the hospital.
Maulik is no stranger to AAMC. He has served as an AAMC Board Trustee for the past five years and has chaired the Board Quality and Patient Safety Committee. After seven years of commuting to Chicago, joining AAMC as EVP and COO allows him to be closer to his family and home on the Eastern Shore. More details regarding Maulik’s arrival will be shared with you in the coming weeks.
The second annual AAMC Joint Outcomes Report: provides a summary of the joint replacement program’s patient-reported outcomes, clinical measures, and operational and financial data. New to this year’s report is a specific focus on the Multidisciplinary Rapid Recovery Protocol. Now in its second year of implementation, this integrated, patient-centered care model is driving continuous improvement across the full continuum of care for our patients.
Consistently ranked the highest-volume joint replacement program in the state, AAMC now performs more than 2,000 surgeries each year—the first program in Maryland to do so. Patients not only come to our program from all across Maryland, but from all over the country to regain independence and improve their quality of life. Now in its second year of publication, this report highlights the many notable achievements of our program. We believe publishing these healthcare outcomes enhances our culture of continuous improvement and increases value for patients. At AAMC, our joint replacement team is dedicated to continuously improving the care of our patients, and our program is proud to be a leader in presenting transparent results.
The Fortney Breast Center is enrolling patients for a study collecting information about the BioZorb tissue marker. BioZorb is an FDA-approved, three-dimensional device a surgeon places after removing tissue from the breast. The study focuses on BioZorb’s use during and after surgery to locate the exact site of tissue removal. To learn more, contact Reema Andrade, clinical research coordinator, at x5749.
James Welker, DO, and the Research Institute are conducting a clinical trial studying the effectiveness of Bococizumab, a PCSK9 Inhibitor. This is a new class of drug shown to drastically reduce LDL cholesterol levels in patients with high cholesterol. These patients include those whose LDL cholesterol level remains high despite taking cholesterol-lowering medications and patients who cannot tolerate other cholesterol-lowering medication. If you or someone you know would benefit from learning more about this study, contact Kathy Gray, RN, at x5868 or Kristine Wood, RN, at x5738.
The Anne Arundel Medical Group Plastic Surgery team is made up of highly-trained surgeons with expertise in all forms of reconstructive surgery, including microsurgery and cosmetic surgery. Located in the AAMC Belcher Pavilion, the team provides inpatient plastic surgery services and sees patients in the Breast Center and the AAMG Surgical Specialists office. The practice can be reached at 443-481-3400.
- Devinder Singh, MD, Chief and Medical Director of Plastic Surgery. Dr. Singh is an internationally-known plastic surgeon. He is board-certified in plastic surgery and a member of the American Society of Plastic Surgeons, the American Association of Plastic Surgeons and the Northeastern Society of Plastic Surgeons. He is the current chair of the Maryland State Board of Physicians and serves on the Maryland State Medical Society (MedChi)’s Board of Trustees. Dr. Singh is a nationally-recognized expert in the fields of complex recurrent ventral hernia repair and wound care. He specializes in cosmetic surgery of the breast and abdomen as well as surgery repair. He completed his residency at Yale University for a combined residency in general and plastic surgery in New Haven, Conn. He attended medical school at Columbia University in New York.
- Tripp Holton, MD, Director of Microvascular Surgery. Dr. Holton is a board-certified, fellowship-trained plastic and reconstructive surgeon. He has extensive expertise in reconstructive microsurgery including reconstruction of the head and neck, breast and extremities. He focuses on breast and body contouring as well as facial aesthetic surgery. Dr. Holton is also active in research in the areas of biomaterials and biotechnology. He completed a fellowship in plastic and reconstructive surgery at Johns Hopkins Hospital in Baltimore, Md. He completed a residency in general surgery at University of Maryland Medical Center in Baltimore, Md. He attended medical school at Temple University School of Medicine in Philadelphia, Pa.
- Virginia Lobach, PA-C. Virginia joined the AAMG Plastic Surgery department after completing a one-year surgical residency at Johns Hopkins Hospital. Virginia completed her physician assistant training at the University of Kentucky and received a Bachelor of Science in Psychology from College of Charleston in South Carolina.
After 16 years of service, Heidi Katz, supervisor, Physician Relations, has retired. Heidi joined AAMC in 1999 as a marketing associate supporting Health Care Enterprises’ (HCE) physician recruitment efforts (now Physician Enterprise/Anne Arundel Medical Group) and field-based promotion of programs and specialists. She went on to work on the Business Development team for nine years and in Marketing/Communications for seven years. Best wishes, Heidi!